TGF- β: an important mediator of allergic disease and a molecule with dual activity in cancer development

Belen Tirado-Rodriguez1, Enrique Ortega2, Patricia Segura-Medina3

  • 1Unidad de Investigación en Enfermedades Oncológicas, Hospital Infantil de México Federico Gómez, SS, Dr. Márquez No. 162, Colonia Doctores, Delegación Cuauhtémoc, 06720 México, DF, Mexico.

Insights

Transforming growth factor-beta (TGF-β) impacts cell functions and is linked to diseases. New research explores its role in allergic diseases and cancer progression, opening avenues for novel therapies.

Area of Science:

  • Molecular Biology
  • Immunology
  • Oncology

Background:

  • The transforming growth factor-beta (TGF-β) superfamily regulates critical cellular processes like proliferation and differentiation.
  • TGF-β signaling is implicated in various human diseases, including autoimmune and vascular conditions.
  • The TGF-β pathway involves receptor activation, Smad protein phosphorylation, and subsequent gene transcription.

Purpose of the Study:

  • To review recent studies on the role of TGF-β in allergic diseases and cancer.
  • To explore the emerging field of "allergooncology," investigating the link between allergies and cancer progression.
  • To highlight the potential for new therapeutic strategies targeting TGF-β-related pathologies.

Main Methods:

  • Literature review of recent studies on TGF-β.
  • Analysis of research connecting TGF-β to allergic diseases and cancer.
  • Synthesis of findings related to the "allergooncology" field.

Main Results:

  • TGF-β plays a significant role in regulating cellular functions essential for development.
  • Evidence suggests a correlation between TGF-β activity and the progression of both allergic diseases and cancer.
  • The "allergooncology" field is identifying mechanisms linking allergic inflammation to cancer development.

Conclusions:

  • TGF-β is a key mediator in biological processes and disease pathogenesis.
  • Further research into TGF-β's dual role in allergy and cancer is warranted.
  • Understanding these mechanisms may lead to innovative therapeutic approaches for complex diseases.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
25
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
201
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
80
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.7K